8
Shared Docs
8
Same-Page
8 / 8
Mentions
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
ized Gain/Loss Est. Annual Inc. Accrued Div. Yield Preferred Stocks BARCLAYS BANK PLC 25.54 PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK 8 1/8% 361860-20-8 P MFA FINANCIAL INC PFD 8% 55272X-30-0 MFO PNC FINANCIAL
sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP
5-8 DAG Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CAPITAL ONE FINANCIAL CO PFD 6% 14040H-40-2 COF PP CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK 8 1/8% 361860-20-8 JPMORGAN CHASE & CO PFD 5.500% 48126E-75-0 3PM PD Total P
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
55-8 DAG Preferred Stocks ANNALY CAPITAL MGMT PFD 7 5/8% 035710-70-6 NLY PC BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 26.46 30,000.000 793,800.00 750,000.00 43,800.00 25.16 EFTA01539693 39,250.000 987,530.00 1,002,565.5
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973
5 BSMX Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 P CBL & ASSOCIATES PROP PFD 6 5/8% 124830-80-3 CBLA CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK 8 1/8% 361860-20-8 Account W23560001 Page 6 of 36 Consolidated Statement Page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
% 015271-70-3 ARE PENA /BAA AMERICAN CAPITAL AGENCY 8% PFD 02503X-20-4 AGNC BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK 8 1/8% 361860-20-8 P KIMCO REALTY CORP 6% PFD 49446R-79-4 KIM PI 24.96 0.00
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
0/12 Price Preferred Stocks ANNALY CAPITAL MGMT PFD 7 5/8% 035710-70-6 NLY BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 P ENTERGY LOUISIANA LLC PFD 5 1/4% 29364W-50-4 GMAC CAPITAL TRUST I PFD STK 8 1/8% 361860-20-8 Total Pref
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
JAN 25 2037 DTD 02/27/2007 (ID: 05952H-BY-4) CITICORP MORTGAGE SECURITIES SER 2005-1 CL B2 5.4204% FEB 25 2035 DTD 02/01/2005 (ID: 172973-P9-4) CITIGROUP CAPITAL XIII 7 7/8% PFD @ 0.492187 PER SHARE (ID: 173080-20-1) 30,000.000 0.492 14,765.61 $232,026.42 2,072,272.230 0.005 9,364.52 2,043,869.546 0.005
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 138.21 09062X-10-3 BIIB 16.84 242370-10-4 DF 21.11 30303M-10-2 FB Total US Large Cap Equity $1
BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% @ 25.86838 1,015,333.92 BROKERAGE 1,570.00 TAX &/OR SEC 22.75 J.P. MORGAN SECURITIES LLC (ID: 06739H-36-2) CITIGROUP CAPITAL XIII 7 7/8% PFD @ 28.45029 853,508.70 BROKERAGE 1,200.00 TAX &/OR SEC 19.12 J.P. MORGAN SECURITIES LLC (ID: 173080-20-1) COPANO ENERGY LLC @ 31.81882
Entities connected to both BIOGEN IDEC INC and CITIGROUP CAPITAL XIII

Ghislaine Maxwell
PERSON
JPMorgan Chase
ORGANIZATION
the Internal Revenue Service
ORGANIZATIONSecurities Investor Protection Corporation
ORGANIZATIONGlobal Access Portfolios
ORGANIZATIONGENERAL MOTORS CO
ORGANIZATION
Bank of America
ORGANIZATION
Newark
LOCATIONJPMorgan Fund
ORGANIZATION
Barclays
ORGANIZATION
Paul Morris
PERSON
Nassau
LOCATION
FDIC
ORGANIZATIONUS Small/Mid Cap Equity
ORGANIZATIONGENERAL MOTORS CO CV
ORGANIZATIONJason Grosse
PERSON
Deutsche Bank
ORGANIZATION
Paul Barrett
PERSONUNCAPPED
ORGANIZATIONCIT GROUP INC
ORGANIZATION